RA

Rite Aid CorpNYSE RAD Stock Report

Last reporting period 03 Jun, 2023

Updated —

Last price

Market cap $B

0.037

Micro

Exchange

XNYS - New York Stock Exchange, Inc

RAD Stock Analysis

RA

Uncovered

Rite Aid Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-31/100

Low score

Market cap $B

0.037

Dividend yield

Shares outstanding

56.523 B

Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 53,000 full-time employees. The firm is engaged in providing its service to customers and communities through various programs. Its business segments include the Retail Pharmacy segment and Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates over 2,300 retail pharmacy locations across 17 states. The Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The firm's clients include employers, insurance companies and unions.

View Section: Eyestock Rating